Morpholino

MO2-slc25a17

ID
ZDB-MRPHLNO-200406-2
Name
MO2-slc25a17
Previous Names
None
Target
Sequence
5' - ATGGAGCCAACCTGGAGACAAAGAG - 3'
ZFIN BLAST NCBI BLAST Ensembl UCSC BLAT
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
Splice-blocking MO.
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO2-slc25a17
Expressed Gene Anatomy Figures
acox1 Fig. 3 from Kim et al., 2019
acta2 Fig. 5 from Kim et al., 2019
agps Fig. 3 from Kim et al., 2019
foxa3 Fig. 5 from Kim et al., 2019
hprt1l Fig. 5 from Kim et al., 2019
hsd17b4 Fig. 3 from Kim et al., 2019
mnx1 Fig. 5 from Kim et al., 2019
pex5 Fig. 3 from Kim et al., 2019
psap Fig. 5 from Kim et al., 2019
scp2a Fig. 3 from Kim et al., 2019
sox2 Fig. 5 from Kim et al., 2019
Phenotype
Phenotype resulting from MO2-slc25a17
Phenotype Fish Figures
gut foxa3 expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
liver foxa3 expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
liver decreased size, abnormal gz15aTg + MO2-slc25a17 Fig. 5 from Kim et al., 2019
myelination in peripheral nervous system disrupted, abnormal ck1Tg + MO2-slc25a17 Fig. 4 from Kim et al., 2019
pancreatic bud foxa3 expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
swim bladder uninflated, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
swim bladder lipid amount, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
swim bladder bud psap expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
swim bladder bud epithelium sox2 expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
swim bladder bud epithelium mnx1 expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
swim bladder bud mesenchyme acta2 expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
swim bladder bud mesothelial cell hprt1l expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
swim bladder development disrupted, abnormal WT + MO2-slc25a17 Fig. 5 from Kim et al., 2019
whole organism hsd17b4 expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 3 from Kim et al., 2019
whole organism scp2a expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 3 from Kim et al., 2019
whole organism acox1 expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 3 from Kim et al., 2019
whole organism pex5 expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 3 from Kim et al., 2019
whole organism agps expression decreased amount, abnormal WT + MO2-slc25a17 Fig. 3 from Kim et al., 2019
whole organism decreased length, abnormal WT + MO2-slc25a17 Fig. 3 from Kim et al., 2019
whole organism dioleoyl phosphatidylglycerol decreased amount, abnormal WT + MO2-slc25a17 Fig. 4 from Kim et al., 2019
whole organism hexacosenoate increased amount, abnormal WT + MO2-slc25a17 Fig. 4 from Kim et al., 2019
whole organism hexadecanoate ester decreased amount, abnormal WT + MO2-slc25a17 Fig. 4 from Kim et al., 2019
whole organism Mycolipanolic acid (C24) increased amount, abnormal WT + MO2-slc25a17 Fig. 4 from Kim et al., 2019
whole organism octadecanoate ester decreased amount, abnormal WT + MO2-slc25a17 Fig. 4 from Kim et al., 2019
yolk area, abnormal WT + MO2-slc25a17 Fig. 3 from Kim et al., 2019
Phenotype of all Fish created by or utilizing MO2-slc25a17
Phenotype Fish Conditions Figures
swim bladder bud mesothelial cell hprt1l expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
yolk area, abnormal WT + MO2-slc25a17 standard conditions Fig. 3 from Kim et al., 2019
whole organism hexadecanoate ester decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 4 from Kim et al., 2019
swim bladder bud epithelium sox2 expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
whole organism hexacosenoate increased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 4 from Kim et al., 2019
swim bladder bud epithelium mnx1 expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
swim bladder lipid amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
swim bladder bud psap expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
pancreatic bud foxa3 expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
whole organism octadecanoate ester decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 4 from Kim et al., 2019
swim bladder uninflated, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
whole organism agps expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 3 from Kim et al., 2019
whole organism scp2a expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 3 from Kim et al., 2019
whole organism acox1 expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 3 from Kim et al., 2019
whole organism dioleoyl phosphatidylglycerol decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 4 from Kim et al., 2019
whole organism pex5 expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 3 from Kim et al., 2019
liver foxa3 expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
whole organism hsd17b4 expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 3 from Kim et al., 2019
swim bladder inflated, ameliorated WT + MO2-slc25a17 chemical treatment by injection: coenzyme A Fig. 7 from Kim et al., 2019
swim bladder development disrupted, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
swim bladder bud mesenchyme acta2 expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
gut foxa3 expression decreased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
whole organism Mycolipanolic acid (C24) increased amount, abnormal WT + MO2-slc25a17 standard conditions Fig. 4 from Kim et al., 2019
whole organism decreased length, abnormal WT + MO2-slc25a17 standard conditions Fig. 3 from Kim et al., 2019
myelination in peripheral nervous system disrupted, abnormal ck1Tg + MO2-slc25a17 standard conditions Fig. 4 from Kim et al., 2019
liver decreased size, abnormal gz15aTg + MO2-slc25a17 standard conditions Fig. 5 from Kim et al., 2019
Citations
Your Input Welcome
We welcome your input and comments. Please use this form to recommend updates to the information in ZFIN. We appreciate as much detail as possible and references as appropriate. We will review your comments promptly.
Please check the highlighted fields and try again.
Thank you for submitting comments. Your input has been emailed to ZFIN curators who may contact you if additional information is required.
Oops. Something went wrong. Please try again later.